The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista do Colégio Brasileiro de Cirurgiões |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035 |
Resumo: | Objective: Io evaluate the expression of p16INK4a and p53 biomarkers in conization specimens from patients with high grade cervical intraepithelial neoplasia (HG-CIN), correlating them with the ability to predict the recurrence. Methods : we conducted a retrospective study of patients with HG-CIN in cervical biopsy treated with conization between January 1999 and January 2006 who had a minimum follow-up of 18 months. The expression of the p16 and p53 was assessed by tissue microarrays and correlated with disease recurrence. For analysis, we used the test of proportions (chi-square), considering value p<0.05, 95% CI and calculations of sensitivity, specificity and accuracy of these immunomarkers in predicting recurrence. Results : the series comprised 83 patients aged between 16 and 86 years (35±11.7), divided into two groups: 30 with HG-CIN recurrence (study group) and 53 without recurrence (control group). Mean age, parity, smoking and conization technique were similar in both groups. The p53 expression was present in 43% of the study group and 57% of the control group, and the p16 was present in 43% of the study group and in 57% of the control group (p>0.05). p53 had a positive predictive value (PPV) of 42% and negative predictive value (NPV) of 73%, sensitivity 70%, specificity of 47% and accuracy of 59%. The p16, PPV 42%, NPV 72%, sensitivity 66%, specificity of 49% and accuracy of 56%. Conclusion : immunohistochemistry expression of p53 and p16 showed low sensitivity and low specificity as predictors of HG-CIN recurrence after conization treatment. |
id |
CBC-1_80358fdd15ded114f4220aec08cb241e |
---|---|
oai_identifier_str |
oai:scielo:S0100-69912016000100035 |
network_acronym_str |
CBC-1 |
network_name_str |
Revista do Colégio Brasileiro de Cirurgiões |
repository_id_str |
|
spelling |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatmentCervical Intraepithelial NeoplasiaConizationRecurrenceBiological Markers Objective: Io evaluate the expression of p16INK4a and p53 biomarkers in conization specimens from patients with high grade cervical intraepithelial neoplasia (HG-CIN), correlating them with the ability to predict the recurrence. Methods : we conducted a retrospective study of patients with HG-CIN in cervical biopsy treated with conization between January 1999 and January 2006 who had a minimum follow-up of 18 months. The expression of the p16 and p53 was assessed by tissue microarrays and correlated with disease recurrence. For analysis, we used the test of proportions (chi-square), considering value p<0.05, 95% CI and calculations of sensitivity, specificity and accuracy of these immunomarkers in predicting recurrence. Results : the series comprised 83 patients aged between 16 and 86 years (35±11.7), divided into two groups: 30 with HG-CIN recurrence (study group) and 53 without recurrence (control group). Mean age, parity, smoking and conization technique were similar in both groups. The p53 expression was present in 43% of the study group and 57% of the control group, and the p16 was present in 43% of the study group and in 57% of the control group (p>0.05). p53 had a positive predictive value (PPV) of 42% and negative predictive value (NPV) of 73%, sensitivity 70%, specificity of 47% and accuracy of 59%. The p16, PPV 42%, NPV 72%, sensitivity 66%, specificity of 49% and accuracy of 56%. Conclusion : immunohistochemistry expression of p53 and p16 showed low sensitivity and low specificity as predictors of HG-CIN recurrence after conization treatment.Colégio Brasileiro de Cirurgiões2016-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035Revista do Colégio Brasileiro de Cirurgiões v.43 n.1 2016reponame:Revista do Colégio Brasileiro de Cirurgiõesinstname:Colégio Brasileiro de Cirurgiões (CBC)instacron:CBC10.1590/0100-69912016001008info:eu-repo/semantics/openAccessFonseca,Fernanda VillarTomasich,Flávio Daniel S.Jung,Juliana ElizabethMaestri,Carlos AfonsoCarvalho,Newton Sérgio deeng2016-04-11T00:00:00Zoai:scielo:S0100-69912016000100035Revistahttp://www.scielo.br/rcbcONGhttps://old.scielo.br/oai/scielo-oai.php||revistacbc@cbc.org.br1809-45460100-6991opendoar:2016-04-11T00:00Revista do Colégio Brasileiro de Cirurgiões - Colégio Brasileiro de Cirurgiões (CBC)false |
dc.title.none.fl_str_mv |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
title |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
spellingShingle |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment Fonseca,Fernanda Villar Cervical Intraepithelial Neoplasia Conization Recurrence Biological Markers |
title_short |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
title_full |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
title_fullStr |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
title_full_unstemmed |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
title_sort |
The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment |
author |
Fonseca,Fernanda Villar |
author_facet |
Fonseca,Fernanda Villar Tomasich,Flávio Daniel S. Jung,Juliana Elizabeth Maestri,Carlos Afonso Carvalho,Newton Sérgio de |
author_role |
author |
author2 |
Tomasich,Flávio Daniel S. Jung,Juliana Elizabeth Maestri,Carlos Afonso Carvalho,Newton Sérgio de |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Fonseca,Fernanda Villar Tomasich,Flávio Daniel S. Jung,Juliana Elizabeth Maestri,Carlos Afonso Carvalho,Newton Sérgio de |
dc.subject.por.fl_str_mv |
Cervical Intraepithelial Neoplasia Conization Recurrence Biological Markers |
topic |
Cervical Intraepithelial Neoplasia Conization Recurrence Biological Markers |
description |
Objective: Io evaluate the expression of p16INK4a and p53 biomarkers in conization specimens from patients with high grade cervical intraepithelial neoplasia (HG-CIN), correlating them with the ability to predict the recurrence. Methods : we conducted a retrospective study of patients with HG-CIN in cervical biopsy treated with conization between January 1999 and January 2006 who had a minimum follow-up of 18 months. The expression of the p16 and p53 was assessed by tissue microarrays and correlated with disease recurrence. For analysis, we used the test of proportions (chi-square), considering value p<0.05, 95% CI and calculations of sensitivity, specificity and accuracy of these immunomarkers in predicting recurrence. Results : the series comprised 83 patients aged between 16 and 86 years (35±11.7), divided into two groups: 30 with HG-CIN recurrence (study group) and 53 without recurrence (control group). Mean age, parity, smoking and conization technique were similar in both groups. The p53 expression was present in 43% of the study group and 57% of the control group, and the p16 was present in 43% of the study group and in 57% of the control group (p>0.05). p53 had a positive predictive value (PPV) of 42% and negative predictive value (NPV) of 73%, sensitivity 70%, specificity of 47% and accuracy of 59%. The p16, PPV 42%, NPV 72%, sensitivity 66%, specificity of 49% and accuracy of 56%. Conclusion : immunohistochemistry expression of p53 and p16 showed low sensitivity and low specificity as predictors of HG-CIN recurrence after conization treatment. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0100-69912016001008 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Colégio Brasileiro de Cirurgiões |
publisher.none.fl_str_mv |
Colégio Brasileiro de Cirurgiões |
dc.source.none.fl_str_mv |
Revista do Colégio Brasileiro de Cirurgiões v.43 n.1 2016 reponame:Revista do Colégio Brasileiro de Cirurgiões instname:Colégio Brasileiro de Cirurgiões (CBC) instacron:CBC |
instname_str |
Colégio Brasileiro de Cirurgiões (CBC) |
instacron_str |
CBC |
institution |
CBC |
reponame_str |
Revista do Colégio Brasileiro de Cirurgiões |
collection |
Revista do Colégio Brasileiro de Cirurgiões |
repository.name.fl_str_mv |
Revista do Colégio Brasileiro de Cirurgiões - Colégio Brasileiro de Cirurgiões (CBC) |
repository.mail.fl_str_mv |
||revistacbc@cbc.org.br |
_version_ |
1754209213237690368 |